@finchy 

Last reply

finchy

Risk perception and DMDs

Dear colleagues I have posted a recent blog on the subject of risk: how we deal with choices regarding disease modifying drugs. You can see the posting on http://www.whatmsmi.com. I would welcome your own comments.
@Stumbler

@finchy , that's a very good read. However, your analogy, whilst good, isn't quite correct. You are closely monitored to mitigate the risks, so you would have a greater insight into whether the next chamber was loaded. If there were signs that a loaded chamber was next, you'd have a choice of exploring other avenues. But, a good read and I bet it was cathartic writing it. :wink:

@mumofmser

Hi quite thought provoking. I am at the beginning of this journey with my 17 year old daughter not yet had appointment for DMT but think we will be offered lemtrada. She has no ability to weigh up the risks and although a health care professional myself I am too emotionally involved to make such a decision. We do have to place our trust in the consultants making the best decisions with the available evidence and their experience. I find it quite fascinating having worked recently in oncology that this questioning of toxic therapies for cancer is given very little consideration by patients they just want anything you can throw at them. Cancer is a chronic illness for many just like MS. I am hoping they will offer my daughter lemtrada but the potential side effects ITP renal are very concerning. What is I sway the decision and then she has a problem?